In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on optimal management of community-associated MRSA skin infections.

In this Episode, Dr. Thomas M. File, Jr. from Northeastern Ohio Universities College of Medicine in Rootstown, Ohio provides insights on strategies to effectively manage patients with skin and soft tissue MRSA infections.

In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on when an alternative agent to vancomycin should be considered for MRSA infections.

In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on toxicity concerns associated with vancomycin use.

In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on vancomycin therapeutic drug monitoring.

In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on appropriate vancomycin dosing to maximize effectiveness.

In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on vancomycin 'MIC creep', the evidence and its implications.

In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on community-associated MRSA and healthcare-acquired MRSA.

In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on why the prevalence of MRSA is increasing in the hospital setting.

In this Episode, Dr. George Zhanel from University of Manitoba in Canada provides insights on why MRSA is such a problematic pathogen.